Clinical trial

S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients…

NCT00006994 · SWOG Cancer Research Network, Other · Terminated

Key facts

NCT number NCT00006994
Title S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
Official title S9908, A Double-Blind, Placebo-Controlled Trial To Study The Efficacy And Safety Of L-Glutamine (In AES0014 Delivery Vehicle) Upon Radiation Therapy-Induced Oral Mucositis In Head and Neck Cancer Patients, Phase III
Lead sponsor SWOG Cancer Research Network, Other
Collaborators National Cancer Institute (NCI) NIH
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Cancer-related Problem/Condition, Head and Neck Cancer, Pain
Intervention type Dietary Supplement, Drug, Radiation
Interventions glutamine, radiation therapy, l-glutamine placebo
Enrollment 23
Start date Nov 1, 2001
Primary completion Apr 1, 2005
Completion Apr 1, 2006
First posted Jan 27, 2003
Last update posted Nov 18, 2015
Countries Canada, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies